目的:探讨序贯器官衰竭评分(sequential organ failure assessment,SOFA)对肝移植患者术后28d死亡率的早期预测价值。方法:收集2015年1月至2016年9月64例在复旦大学附属中山医院肝外科接受同种异体肝移植手术患者的临床资料,包括一般资...目的:探讨序贯器官衰竭评分(sequential organ failure assessment,SOFA)对肝移植患者术后28d死亡率的早期预测价值。方法:收集2015年1月至2016年9月64例在复旦大学附属中山医院肝外科接受同种异体肝移植手术患者的临床资料,包括一般资料、入院时和肝移植术后1~7d(POD1-7)的生化检查结果、手术相关指标及术后28d(POD28)死亡率等,对相关数据进行统计分析。结果:ROC曲线分析提示,POD1-7的SOFA评分预测患者POD28死亡率的临界值是5.5分,其敏感性为100%,特异性为94.8%;POD1-7的SOFA评分>5分的患者POD28死亡率为33.3%(6/18);外周血中的血小板、总胆红素、凝血酶原时间、肌酐及B型氨基端脑钠肽前体(N-terminal B-type natriuretic peptide,NT-proBNP)等生化指标在SOFA评分>5分患者(n=18)与SOFA≤5分患者(n=46)间差异有统计学意义(P<0.05)。结论:SOFA评分结合血小板、胆红素、凝血酶原时间、NT-proBNP及肌酐等指标能早期有效预测肝移植患者术后28d死亡率。展开更多
[Objective] The aim of this study is to clone the active promoter of golgi membrane glycoprotein GP73. [Method] The sequence within the range of upstream 1 000 bp and downstream 400 bp of transcription initiation site...[Objective] The aim of this study is to clone the active promoter of golgi membrane glycoprotein GP73. [Method] The sequence within the range of upstream 1 000 bp and downstream 400 bp of transcription initiation site was analyzed, the genomic DNA of hepatoma cell line Huh-7 was regarded as template for PCR amplification. The amplified fragment was cloned into recombinant construct with enhanced green fluorescent protein (EGFP) report gene. The expression of EGFP in recombinants were observed under fluorescence microscope after transfection, with the assistant of flow cytometry. [Result] The 1 310 bp ranging between upstream 980 bp and downstream 330 bp of transcription initiation site assumed promoter function. The region contains two core promoters and several conserved sequences including TATA box and many DNA binding sites such as NF-κB, AP1, GC-SP1. [Conclusion] The cloning of the promoter provides a reference for the study of the transcription mechanism of GP73.展开更多
移植物抗宿主病(graft versus host disease,GVHD)是指供体来源的免疫细胞对受体组织器官造成损害引发的一系列临床症状的总称,是肝移植病人术后致死率最高的并发症。自1988年第1例病人被诊断为肝移植术后GVHD以来[1],全球已相继报道...移植物抗宿主病(graft versus host disease,GVHD)是指供体来源的免疫细胞对受体组织器官造成损害引发的一系列临床症状的总称,是肝移植病人术后致死率最高的并发症。自1988年第1例病人被诊断为肝移植术后GVHD以来[1],全球已相继报道数百个临床病例。据统计,肝移植术后GVHD的发病率0.1%-2.0%,病死率65%-85%[2]。但目前尚缺乏统一的诊疗共识。展开更多
文摘[Objective] The aim of this study is to clone the active promoter of golgi membrane glycoprotein GP73. [Method] The sequence within the range of upstream 1 000 bp and downstream 400 bp of transcription initiation site was analyzed, the genomic DNA of hepatoma cell line Huh-7 was regarded as template for PCR amplification. The amplified fragment was cloned into recombinant construct with enhanced green fluorescent protein (EGFP) report gene. The expression of EGFP in recombinants were observed under fluorescence microscope after transfection, with the assistant of flow cytometry. [Result] The 1 310 bp ranging between upstream 980 bp and downstream 330 bp of transcription initiation site assumed promoter function. The region contains two core promoters and several conserved sequences including TATA box and many DNA binding sites such as NF-κB, AP1, GC-SP1. [Conclusion] The cloning of the promoter provides a reference for the study of the transcription mechanism of GP73.
文摘移植物抗宿主病(graft versus host disease,GVHD)是指供体来源的免疫细胞对受体组织器官造成损害引发的一系列临床症状的总称,是肝移植病人术后致死率最高的并发症。自1988年第1例病人被诊断为肝移植术后GVHD以来[1],全球已相继报道数百个临床病例。据统计,肝移植术后GVHD的发病率0.1%-2.0%,病死率65%-85%[2]。但目前尚缺乏统一的诊疗共识。